chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a physician concerning a patient who on an unspecified date was vaccinated with a single dose of MMR II.  It was reported that on an unspecified date "after receiving MMR II the patient experienced a papular rash around the trunk".  The patient called to physician.  It was reported that the patient had recovered at the time of the report.  Additional information has been requested.
After the covid vaccine, I started to experience extreme pain in my lower back, right hip and right leg.  The pain started out minor and steadily got worse over the course of a month. On Oct 5 I visited my Primary Care physician and was prescribed an anti-inflammatory and a steroid. This provided minor relief while taking the steroid but the pain returned and continued to escalate.  On Oct 30 the pain was so severe I was forced to go to the emergency room. they performed an MRI and did not find any reason for the pain. I have subsequently received 2 injections in my spine trying to relieve the pain. The pain has finally started to recede after 4 months. On Dec 31, it felt like a fog had lifted and I really started to feel better.  After the first dose of the covid vaccine, I experienced unbelievable pain in the right side of my mouth, the way that pain lifted was very similar to how the back and leg pain lifted last week. No doctor has been able to explain the pain, they have just called it a neurological flare up.
She said she was itching all over, on her scalp, stomach, thighs and other areas; Little red bumps; She scratches until they become scabs.; She states she is not better.; She started to get a rash; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (She said she was itching all over, on her scalp, stomach, thighs and other areas), RASH ERYTHEMATOUS (Little red bumps), SCAB (She scratches until they become scabs.), MALAISE (She states she is not better.) and RASH (She started to get a rash) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013L20a and 023m20a) for COVID-19 vaccination.     Concurrent medical conditions included Atrial fibrillation.   On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In 2021, the patient experienced PRURITUS (She said she was itching all over, on her scalp, stomach, thighs and other areas), RASH ERYTHEMATOUS (Little red bumps), SCAB (She scratches until they become scabs.), MALAISE (She states she is not better.) and RASH (She started to get a rash). The patient was treated with PREDNISONE for Adverse event, at an unspecified dose and frequency. At the time of the report, PRURITUS (She said she was itching all over, on her scalp, stomach, thighs and other areas), RASH ERYTHEMATOUS (Little red bumps), SCAB (She scratches until they become scabs.), MALAISE (She states she is not better.) and RASH (She started to get a rash) outcome was unknown.            concomitant medications include blood pressure medication. Treatment medication included some cream. Patient states she consulted a dermatologist then saw her PCP that had an intern. Patient states she had a whole house purification system and sent some water to the University thinking it had ferric in there but was high in sodium and might be affecting her blood pressure medication.  Patient has cut out bread, eggs, gluten and not sure what else the  patient can cut out.  Patient states that she is not getting the booster.   Most recent FOLLOW-UP information incorporated above includes: On 08-Nov-2021: Follow-up received contains No New Information.
Site: Itching at Injection Site-Medium, Site: Pain at Injection Site-Severe, Site: Redness at Injection Site-Severe, Site: Swelling at Injection Site-Severe, Systemic: Headache-Mild, Systemic: Joint Pain-Mild, Systemic: Numbness (specify: facial area, extremities)-Mild, Systemic: Tingling (specify: facial area, extemities)-Mild, Systemic: Weakness-Mild, Additional Details: Red and hot to touch on arm and around arm
eye pressure/pain/floaters beginning day after second  vaccine dose and lasted for three days. Lymph node in under arm of injection arm swelling starting day after second vaccine those on January 20 and still swollen and tender on February 10
Acute onset of bilateral thigh (quadriceps) wealness resulting in lower extremity immobility for about 10 hrs.Assoc. with fevereishness.
This report describes hives in a 15 year old female who received Infanrix. It was received from a medical technician and has not been verified by a physician or other healthcare professional. On 08/23/01, the vaccinee received her fourth left thigh dose of Infanrix, a dose of Haemophilus Influenza type b vaccine, and Inactivated Poliovirus vaccine On 08/24/01, the vaccinee developed "hives all over" per the mother. The nurse practitioner administered Benadryl liquid. Symptoms resolved in 24048 hrs. As of 08/28/01, the adverse events had resolved.
Tested positive for COVID-19; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of COVID-19 (Tested positive for COVID-19) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Jan-2021, the patient experienced COVID-19 (Tested positive for COVID-19). At the time of the report, COVID-19 (Tested positive for COVID-19) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 16-Jan-2021, SARS-CoV-2 test: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.  No treatment information was provided.  Patient was due for second dose on 08 Feb 2021.
Crippling affect, very difficult moving, movement created  extreme pain causing me to scream when I moved, all muscles hurt (continuous) Bed ridden for two days ... still in severe pain
This spontaneous report was received from a physician via company representatives referring to a patient of unknown age and gender. Information about the patient's pertinent medical history, concomitant medications, drug reactions and allergies was not provided. On 06-JUN-2016, the patient was vaccinated with a dose of improperly stored VAQTA 50U/1ml, lot number: L036878 with expiration date of 26-MAY-2017 (route of administration was not reported). The vaccine was stored at a highest recorded temperature of 49F (9.444444444 Celsius) for 128 hours. The vaccine status was reported as excursion and the storage criteria and the vaccine excursion were reported as "Refrigerator (R)". No adverse event was reported. No Product Quality Complaint (PQC) was involved. This is one of several cases from the same reporter. Additional information has been requested.
No additional AE information reported; Expired MMR II was administered to a patient; This spontaneous report was received from a medical assistant referring to a currently 14-month-old patient of unknown gender. Patient's concurrent conditions, medical history and concomitant medications were not provided.  On 21-JAN-2022, the patient was vaccinated with expired dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II), 0.5 milliliter (Lot # not provided but expiration date reported as 08-JAN-2022) for prophylaxis (expired product administered). There was no current temperature excursion or any previous excursion. No additional AE information reported. No PQC reported.
Patient calls pharmacy & states she has a rash visible at site of vaccine injection (over triceps muscle of left arm). Pt advised to contact Primary Care Provider. As per vaccine administrator's follow-up with MD on 5/24/13, pt never contacted office; office to follow-up with pt.
Information has been received from a licensed practical nurse concerning a 17 year old male patient who on an unspecified date was vaccinated with the first dose of GARDASIL (Lot# not reported). It was reported that the patient had a syncopal episode in the exam room and was examined. At the time of the report the patient's outcome was unknown. This is one of several reports received from the same source. Additional information has been requested.
BODY ACHES, BLURRED VISION, STOMACH CRAMPING, RASH AT INJECTION SITE, CHEST PAINS
I sat for 15 minutes and felt fine but when I was leaving I had to climb up a set of stairs, after doing that I felt light headed and out of breath. That continued for about 15-20 minutes.  At 30 minutes after the injection my voice went hoarse. About an hour after I had a serve bullet like headache in one point in my head, I took Tylenol and lasted for about 5 hours.  I started taking Benadryl (25mg), the headed improved, but when I woke up in the morning the next day I had all over swelling to the the point where I couldn't make a fist and had facial swelling .  The facial swelling lasted for 5 days. My co worker took my vitals signs but everything was normal. For the next 5 days I had facial swelling that increased, hands got better. I continued to Benadryl . After the 5th day things finally started to get better. I did go back to have my second dose.  I contacted my PCP but he was out of town .
Headache 12/24 dizziness, lethargy 12/26-12/27 itchy dry eyes 1/1 headache, 1/5-1/7 dry white pus around eyes Narrative:  12/24 afternoon 15-20 minutes dizziness, slept a little bit. 12/26-27 itchy eyes hx of dry itchy eyes, but reports not like this. 1/1 headache for 4 hr, back neck usually never have a headaches. 1/5-1/7 dry white pus around eyes. Instructed to call covid hotline for rule out. 1/7 Covid result negative. RN will follow up.
Severe body aches in muscles and joints primarily upper legs in the groin area, shoulder to shoulder across the top of my back and up both sides of my neck behind my ears, upper arms, and upper legs.
Pt recvd 3 doses of Engerix-B & did not respond; pt recvd addtl 3 doses of Engerix-B & still did not respond;
Three year old. Nine days after vaccination she had a fever of 101.9, and threw up. Took her to the Dr., and upon examination the Dr. didn't think it was a reaction to the vaccine. Given a COVID-19 test and it was negative. Took her home and gave her TYLENOL. She was sick for about 3 days, and is better now.
product storage error; doses were given after expiration date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (doses were given after expiration date) and PRODUCT STORAGE ERROR (product storage error) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Nov-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (doses were given after expiration date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (product storage error). At the time of the report, EXPIRED PRODUCT ADMINISTERED (doses were given after expiration date) and PRODUCT STORAGE ERROR (product storage error) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication were given. No adverse event were reported. No treatment information were provided. Date of placing in refrigerator is 22nd September 2021
pt recvd vax & 6 wks later when pt went to the blood bank to donate blood, routine testing showed the test for HTLV-1 to be pos/indeterminate;
He developed a mid-grade fever. It got up to 102 and we gave him Children?s Tylenol. He started complaining of a belly ache and lethargy. This lasted for about 48 hours, and he was back to normal. We tested him at the doctor office for COVID-19 and Flu and he was negative. The doctor recommended we give Tylenol if his fever got above 102, but fortunately it did not. No medications were prescribed.
Swelling, numbness of injection limb, extending distally to hand.  Patient was taken to ED.  Treating physician prescribed antibiotics but advised notification of immunizer as possible adverse event.
Information has been received from a consumer concerning her 70 year old husband with no pertinent medical history or drug reactions/allergies who on 31-MAR-2011 was vaccinated with a dose of ZOSTAVAX (Merck) (dose, route and lot# not reported) into his arm. Concomitant therapy included COUMADIN as well as unspecified blood pressure and cholesterol medications. On 02-APR-2011 the patient woke up with a terrible pain in his ear and he could not hear out of that ear. He never had rash, but he had blotches on his face. He was experiencing nerve pain that came and went, but he always had an ache. The nerve pain started at his right temple and spread to his jaw and ear. Since all of this started, they had gone to an ENT (ear, nose and throat doctor) and the patient was prescribed an antibiotic (unspecified). Later, the patient was prescribed a viral medication (unspecified) after the ENT realized the pain was related to his nerves. The reporter believed the patient was experiencing postherpetic neuralgia. The patient went for the vaccine as a healthy individual. The patient was treated with VALTREX, prednisone, NEURONTIN and codeine medication (unspecified). Recently, the patient went to ER (emergency room) because he had H.O.Fibrillation and was not admitted. No lab diagnostics study was performed. At the time of reporting, the patient had not recovered. Upon internal review, deafness was considered to be an other important event. Additional information has been requested.
1) 25 minutes from injection: fluttering heartbeat, hot flush spreading from arm throughout body, weakness in arm and then all over, shaking, dry mouth and tongue.  The worst of it lasted about 5 minutes but weakness and shaking continued for about an hour.  2) Over the course of several hours developed sore arm and headache which worsened over the next 12 hours but was not terribly bad.  3) Days 3-6 had stiffness which began at injection site and went up left shoulder into the left side of neck.  Resolved by day 7.  4) ON DAY EIGHT I developed a rash and itching at the injection site.  Also had a dry cough and sinus drainage but cannot be certain this was from the vaccination but the rash and itching definitely was.  The rash resolved by day 12.  It was not terribly bad and no drugs were needed to calm the itch.
Pt came to the counsel window last night and said she needed to get her second dose of the Shingrix vaccine but was concerned because she said after receiving the vaccine she developed a red, itchy, 2 inch  raised rash at the injection site that lasted about 2 weeks. I told her I would report the adverse event and contact both the manufacturer and her primary care doctor to see clinically if she should get the second dose or to not complete the series.
Large inflammatory skin reaction surrounding injection site 24 hours after receiving influenza vaccine, temp 101.
Patient fainted. Got up and was pale, sweating, pulse around 70. (Upon speaking to patient this episode of fainting happened prior at an airport.)
adverse effect because others had similar reaction/others are having the same symptoms; This spontaneous case was reported by a consumer and describes the occurrence of IMMUNISATION REACTION (adverse effect because others had similar reaction/others are having the same symptoms) in a female patient of an unknown age who received mRNA-1273 (Spikevax) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, the patient experienced IMMUNISATION REACTION (adverse effect because others had similar reaction/others are having the same symptoms). At the time of the report, IMMUNISATION REACTION (adverse effect because others had similar reaction/others are having the same symptoms) outcome was unknown. The action taken with mRNA-1273 (Spikevax) (Unknown) was unknown. No relevant concomitant medications were reported.  No treatment information was provided.  The patient states that she saw nothing online how to help, but now she was seeing articles that suggest this was an adverse effect because others had similar reaction. She was suspicious that this is an adverse effect, so she would like it reported. The patient stated she was happy that Moderna produced this vaccine. She was important that others are having the same symptoms and to report it to make it as safe as possible.   This case was linked to MOD-2021-261769, MOD-2022-585174 (Patient Link).
Pain where shot was given (day after). Redness and swelling where shot was given (day after). Headache (for week and half). Tiredness (week and half). Nausea, vomiting, stomach cramps (2 weeks). Burning inside ears. Missed 3 days of school.
Became dizzy, light headed slight shortness of breath. Hypertensive tachycardiac
1 year old covered in small red dots.  Raised red bump, infected area at the site of injection.  The site of injection is painful two weeks later.  Small red dots have persistent since immunization, which was nearly two weeks ago.
Had the shingles shot/Suspected vaccination failure; Got Shingles; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a elderly male patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.     Additional Information: GSK receipt date: 22-Jul-2022 Reporter's comment: The case was received from the consumer via interactive digital media. The reporter knew that the patient in his 70s had the shingles shot and got the shingles. Additional supportive information: This case was considered as suspected vaccination failure since the details regarding the completion of primary vaccination schedule, time to onset and laboratory confirmation of shingles were unknown at the time of reporting. The follow-up could not be possible as no contact details were available.
severe diffuse arthralgias, myalgias, t101.2, chills, nausea, shooting pain through body;serum allergy;
Sharp throbbing pain in the left arm pit. Dull nerve pain shooting down left arm from shoulder to wrist.  Pain started the morning after vaccination.  Swollen and tender shoulder noted with limited mobility and range of motion. Had no other health condition or disability prior to this.
Initial unsolicited report received from a Nurse on 07-Nov-2017. This case involves 57-year-old female patient who was vaccinated with FLUBLOK VACCINE (batch number, expiry date, route, dose in series, was not reported) on 10-Oct-2017. Patient's medical history were not reported. Concomitant medications were not reported. It was also reported that patient experienced allergic reaction to the flu shot (last one received when she was 17 year). On an unknown date, one week after the vaccination patient had lethargy, high blood pressure, chest tightness, severe dyspnea, color was ashen without rash. Patient did see an Advanced Practice Registered Nurse, EKG, and lab work were all negative and corrective treatment were not reported. On an unknown date, patient got recovered from the events as symptoms lasted approximately 24-30 hours. Follow up report received from a nurse on 28-Mar-2018. The patient was vaccinated with a 0.5 ml dose of FLUBLOK VACCINE (batch number: QFAA1703, expiry date: 26-Mar-2018, dose in series was not reported) via intramuscular route in the right deltoid. The patient had no concurrent conditions and concomitant medications. The patient also had no pre-existing physician-diagnosed allergies or birth defects. On 19-Oct-2017, nine-days (reported as 'one-week') following the vaccination, the patient developed high blood pressure, lethargy, color was ashen, severe dyspnea and chest tightness. On 19-Oct-2017, the patient visited to ARNP and provider note stated that patient had symptoms two days prior after she took her dog for walk and no mention of FLUBLOK VACCINE was there. The patient's lab test includes EKG (electrocardiogram) showed sinus rhythm with ectopy or acute As (as reported). Documents held by sender: none
Headache, NauseaVomiting, arm soreness Narrative:  Headache, nausea, arm soreness at  injection site.
Mild fever and severe body chills beginning at about 4:00 to 4:30 am on Monday, April 12, 2021 (which lasted for only about two-to-three hours) Mild-to-severe abdominal pain beginning at about 12:30 pm on Tuesday, April 13, 2021 (ongoing and no treatment as of yet)
4" AREA OF ERYTHEMA AND SWELLING AT SITE OF VARICELLA VACCINATION
A consumer report has been received. The report concerns a male consumer, who had been receiving nasal FLUMIST (intranasal). Concomitant medications included UNSPECIFIED). FLUMIST (INTRANASAL) started on an unknown date. The patient experienced EXPERIENCING A FEVER FOR THE PAST 36 HOURS, WHICH SPIKED. The outcome of the event of EXPERIENCING A FEVER FOR THE PAST 36 HOURS, WHICH SPIKED is unknown. The report was considered to be non-serious.
The day after the second shot 09/21 headache as well as fatigue. On 10/11 in the afternoon I started feeling a pain on the left side of my chest, took Tums thinking Heartburn. Went to bed that night, pain was still there the next morning 10/12. Went to Emergency Dept at 8:56am to rule out heart attack. EKG normal, Troponin-I 5 ng/L , CBC showed D-Dimer 1.43 mg/L FEU. Chest X-Ray followed by CT w/ contrast showed "acute emboli within the left pulmonary artery, the left superior segmental artery, the superior lingular artery and the right posterior basal segmental artery. No evidence of right ventricular strain." Emergency Dept released me to follow up with Dr hematology, given Xarelto PE starter PK. 10/25 Venous Doppler lower extrem-bilat finding "the distal popliteal vein as well as the posterior tibial vein are occluded due to thrombus." Right leg normal as well as left common femoral and femoral vein.
This spontaneous case, initially received from other health professional on 26-Sep-2018, concerns a 21-year-old, adult, male patient. The patient's concomitant medications included GARDASIL 9. On 24-Sep-2018, the vaccines were out of the recommended range for 1 hour and minimum temperature reached was 33.8 Fahrenheit. It was the first temperature excursion (explicitly coded as incorrect product storage). On the same day, the patient was administered FLUCELVAX QIVc [dose: 0.5 ml, route of administration: intramuscular, anatomical location: deltoid, batch number: 252670 and expiry date: 30-Jun-2019), that underwent temperature excursion (explicitly coded as drug administration error). The patient did not experience any adverse event after administration of the vaccine. The reporter assessed the case as non-serious. This case was cross-linked to the case: 201804150 reported by the same reporter.